<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33346">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01753219</url>
  </required_header>
  <id_info>
    <org_study_id>Onli</org_study_id>
    <nct_id>NCT01753219</nct_id>
  </id_info>
  <brief_title>Onstep Versus Lichtenstein, the Onli Trial.</brief_title>
  <acronym>Onli</acronym>
  <official_title>Effect of Suture for Mesh Fixation on Pain and Other Complications in Patients Undergoing Inguinal Hernia Repair: a Double-blind, Randomized Study Comparing the Lichtenstein With the Onstep Technique - the ONLI Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jacob Rosenberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Herlev Hospital</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <authority>Denmark: Danish Health and Medicines Authority</authority>
    <authority>Denmark: Ethics Committee</authority>
    <authority>Denmark: National Board of Health</authority>
    <authority>Denmark: The Ministry of the Interior and Health</authority>
    <authority>Denmark: The Regional Committee on Biomedical Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate chronic pain and sexual dysfunction after
      inguinal hernia repair involving mesh fixation with sutures (Lichtenstein) compared with no
      mesh fixation (Onstep). The study hypothesis is that a smaller proportions of patients
      operated without mesh fixation (Onstep) will have chronic pain that impairs daily function.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Proportion of patients with chronic pain that impairs daily function</measure>
    <time_frame>6 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>At the 6 month follow up, all participants will be asked to fill out questionnaires regarding pain. Questionnaire used will assess degree of pain and degree of impairment on daily function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of patients with pain related impairment of sexual function</measure>
    <time_frame>6 month + 12 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>At 6 and 12 month followup participants will be asked to fill out a questionnaire assessing pain related impairment of sexual function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of patients with pain that impairs daily function</measure>
    <time_frame>12 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>At the 12 month follow up, all pariticipants will be asked to fill out qestionnares regarding pain. Questionnaire used will assess degree of pain and degree of impairment of daily function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Early postoperative pain</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>During the first 10 days, level of pain will be assessed using a Visual Analog Scale.</description>
  </primary_outcome>
  <other_outcome>
    <measure>30 day complications</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Complications, occuring within the first 30 postoperative days will be recorded by telephone interview on day 30.</description>
  </other_outcome>
  <other_outcome>
    <measure>Cut to suture time</measure>
    <time_frame>Peroperative</time_frame>
    <safety_issue>No</safety_issue>
    <description>The cut to suture time will be recorded by the staff in the operating room.</description>
  </other_outcome>
  <other_outcome>
    <measure>Lenght of hospital stay</measure>
    <time_frame>Days</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Time to return to normal daily activities</measure>
    <time_frame>Days or weeks</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <other_outcome>
    <measure>Patients comfort</measure>
    <time_frame>6 and 12 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients comfort with the operated hernia be assessed using questionnaires.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">282</enrollment>
  <condition>Hernia, Inguinal</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Onstep</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will have a inguinal hernia repair ad modum Onstep.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lichtenstein</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group will receive a inguinal hernia repair ad modum Lichtenstein.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Onstep</intervention_name>
    <arm_group_label>Onstep</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lichtenstein</intervention_name>
    <arm_group_label>Lichtenstein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnose of a primary groin hernia that requires surgical intervention.

          -  Eligible for procedure performed under general anesthesia

        Exclusion Criteria:

          -  Not able to understand Danish, written and spoken.

          -  Emergency procedures

          -  Previous inguinal hernia on ipsilateral side.

          -  ASA score more than 3.

          -  Incarcerated or irreducible hernia.

          -  Local (site of surgery) or systemic infection.

          -  Contralateral hernia being operated at the same time or planned operated  during
             follow-up.

          -  Other abdominal hernias being operated at the same time or planned operated during
             follow-up.

          -  Previous surgery that has impaired the sensation in the groin area.

          -  BMI &gt; 40 or &lt; 20.

          -  Daily intake of alcohol &gt;5 units, 1 unit = 12g pure alcohol.

          -  Known disease that impairs central or peripheral nerve function.

          -  Concurrent malignant disease.

          -  Impairment of cognitive function (e.g. dementia).

          -  Chronic pain that requires daily medication.

          -  Mental disorder that requires medication.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacob Rosenberg, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>University of Copenhagen, Herlev Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristoffer Andresen</last_name>
    <phone>+ 45 25 46 84 24</phone>
    <email>kristofferandresen@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jakob Burcharth</last_name>
    <phone>+45 26 23 73 23</phone>
    <email>jakobburcharth@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <state>Capital Region</state>
        <zip>2200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristoffer Andresen</last_name>
      <phone>+45 25 46 84 24</phone>
      <email>kristofferandresen@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jakob Burcharth</last_name>
      <phone>+ 45 26 27 62 26</phone>
      <email>jakobburcharth@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospitalsenheden Horsens</name>
      <address>
        <city>Horsens</city>
        <state>Region Midt</state>
        <zip>8700</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maj-Britt Errebo, MD</last_name>
      <phone>+4578426339</phone>
      <email>Maj.Britt.Errebo@aarhus.rm.dk</email>
    </contact>
    <investigator>
      <last_name>Maj-Britt Errebo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hobro Sygehus</name>
      <address>
        <city>Hobro</city>
        <zip>9500</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fritz Sørensen, MD</last_name>
      <email>fss@rn.dk</email>
    </contact>
    <investigator>
      <last_name>Fritz Sørensen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kolding Sygehus</name>
      <address>
        <city>Kolding</city>
        <zip>6000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesper Bjerg, MD</last_name>
      <email>Jesper.Bjerg@slb.regionsyddanmark.dk</email>
    </contact>
    <investigator>
      <last_name>Jesper Bjerg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.cpodenmark.dk</url>
    <description>Research group conducting this trial</description>
  </link>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 9, 2013</lastchanged_date>
  <firstreceived_date>December 17, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Herlev Hospital</investigator_affiliation>
    <investigator_full_name>Jacob Rosenberg</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
